Early presentation of metastatic medullary carcinoma in multiple endocrine neoplasia, type IIA: Implications for therapy
Open Access
- 30 September 1996
- journal article
- case report
- Published by Elsevier in The Journal of Pediatrics
- Vol. 129 (3) , 459-464
- https://doi.org/10.1016/s0022-3476(96)70084-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- APPLICATION OF GENETIC SCREENING INFORMATION TO THE MANAGEMENT OF MEDULLARY THYROID CARCINOMA AND MULTIPLE ENDOCRINE NEOPLASIA TYPE 2Endocrinology and Metabolism Clinics of North America, 1996
- The practical management of multiple endocrine neoplasiaTrends in Endocrinology & Metabolism, 1995
- Medullary Thyroid Carcinoma, Genes, and the Prevention of CancerNew England Journal of Medicine, 1994
- Clinical Screening as Compared with DNA Analysis in Families with Multiple Endocrine Neoplasia Type 2ANew England Journal of Medicine, 1994
- Predictive DNA Testing and Prophylactic Thyroidectomy in Patients at Risk for Multiple Endocrine Neoplasia Type 2AAnnals of Surgery, 1994
- Mutations in the RET proto-oncogene are associated with MEN 2A and FMTCHuman Molecular Genetics, 1993
- Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2ANature, 1993
- Medullary Carcinoma in ChildrenArchives of Surgery, 1989
- Provocative testing for occult medullary carcinoma of the thyroid: Findings in seven children with multiple endocrine neoplasia type IIaJournal of Pediatric Surgery, 1987
- Total thyroidectomy for occult familial medullary carcinoma of the thyroid in childrenJournal of Pediatric Surgery, 1976